{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT04351724: Phase 2/Phase 3 Interventional Unknown status COVID-19
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02535104: Phase 1/Phase 2 Interventional Completed Condylomata Acuminata
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01387347: Phase 2 Interventional Completed Dry Eye Syndrome
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01392547: Phase 3 Interventional Completed Congenital Bleeding Disorder
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00528333: Phase 2 Interventional Completed Acute Myeloid Leukemia
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04289103: Phase 3 Interventional Unknown status Steroid Refractory GVHD
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04311632: Phase 2 Interventional Completed Kidney Transplantation
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04577300: Phase 2 Interventional Recruiting Glaucoma
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04383210: Phase 2 Interventional Terminated Locally Advanced Solid Tumor
(2024)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02466516: Phase 2 Interventional Completed Non-Alcoholic Steatohepatitis (NASH)
(2015)
Source URL:
Class:
PROTEIN